Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A corneal dystrophy (disease) that involves the corneal epithelium.
Biomarker and diagnostic research for corneal endothelial dystrophy has been reported in the published literature.
4 clinical trials registered, 3 recruiting. Interventions under study include drug therapy, other interventions, gene therapy, and biologic therapy. Pipeline includes 1 PHASE3, 1 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
181 publications have been identified in PubMed for corneal endothelial dystrophy. Research spans Basic Science / Preclinical (31%), Clinical Trial Publication (18%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 56 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:15 AM UTC
31%
Clinical study results | 33 | 18% |
Research summaries | 26 | 14% |
Disease patterns and progression | 22 | 12% |
Patient case studies | 16 | 9% |
New treatment approaches | 14 | 8% |
Testing and diagnosis research | 12 | 7% |
Other research | 2 | 1% |
Yang L (2026). [PMID: 41644445](https://pubmed.ncbi.nlm.nih.gov/41644445/). *[Zhonghua yan ke za zhi] Chinese journal of ophthalmology*. [Clinical Trial Publication]
Milenkovic A (2026). [PMID: 42010707](https://pubmed.ncbi.nlm.nih.gov/42010707/). *Genome Med*. [Gene Therapy / Novel Therapeutics]
Zhou T (2026). [PMID: 41532702](https://pubmed.ncbi.nlm.nih.gov/41532702/). *Invest Ophthalmol Vis Sci*. [Basic Science / Preclinical]
Sahin Vural G (2026). [PMID: 41856174](https://pubmed.ncbi.nlm.nih.gov/41856174/). *Surv Ophthalmol*. [Review / Meta-Analysis]
Kaur K (2026). [PMID: 36256774](https://pubmed.ncbi.nlm.nih.gov/36256774/). *Unknown Journal*. [Diagnostic / Biomarker]
Yao S (2026). [PMID: 42080792](https://pubmed.ncbi.nlm.nih.gov/42080792/). *Invest Ophthalmol Vis Sci*. [Basic Science / Preclinical]
Shimizu T (2026). [PMID: 42080798](https://pubmed.ncbi.nlm.nih.gov/42080798/). *Transl Vis Sci Technol*. [Epidemiology / Natural History]
Arghirescu AM (2026). [PMID: 42195359](https://pubmed.ncbi.nlm.nih.gov/42195359/). *Life (Basel)*. [Basic Science / Preclinical]
Vishwakarma P (2026). [PMID: 40145813](https://pubmed.ncbi.nlm.nih.gov/40145813/). *Cornea*. [Clinical Trial Publication]
Wu D (2026). [PMID: 42101419](https://pubmed.ncbi.nlm.nih.gov/42101419/). *Transl Vis Sci Technol*. [Review / Meta-Analysis]